Darolutamide - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Darolutamide

Brand Name:

Nubeqa

Strength:

300mg

HCPCS:

NA

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Androgen Receptor Inhibitor

Minor Drug Class:

Non-Steroidal

Oral (Y/N):

Yes

FDA Approval Year:

2019

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use